← All trials
NCT03701217
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 10, 2018
- Primary completion
- Sep 30, 2019
- Completion date
- Oct 31, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 220
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Southern Medical UniversityLead sponsor
- People's Liberation Army of ChinaCollaborator
- Southern Medical UniversityCollaborator
- Southern Medical UniversityOverall official - principal investigator
- Southern Medical UniversityReponsible party - principal investigator
- Guangzhou Medical UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
- Dongguan Kanghua HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.